Browse grants
Federal opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying.
DoW’s Energy, Installations, and Environment Innovation Partners Programs
Due Jan 8, 2028Washington Headquarters Services · $0–$100M
A Department of War (Washington Headquarters Services) non-research cooperative agreement program to help manage and sustain DoW land in the U.S. through natural and cultural resource projects supporting installation resilience and military readiness. Eligibility is very broad: public and private agencies, organizations, institutions, and individuals are invited to apply. Awards range widely, up to about $100 million. The broad eligibility, including individuals, is unusual, so confirm specific requirements in the announcement.
NonprofitsSmall businessResearchersIndividuals+4 moreReissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Due May 16, 2028Food and Drug Administration · $0–$900K
Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.
ResearchersNonprofitsSmall businessGovernment / tribal+3 moreBROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
Due Jul 31, 2028Defense Health Agency Contracting Activity - DHACA · $750K–$50M
Open broadly to any type of entity — universities, nonprofits, businesses (including small businesses), and others. This Department of Defense / Defense Health Agency broad agency announcement funds extramural biomedical and human-performance research and development through FY28. Awards span a very wide range, from about $750,000 to $50 million.
ResearchersNonprofitsSmall businessSchools & universities+3 moreUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
Due Oct 20, 2028National Institutes of Health · Up to $200K
This NIH R21 grant funds secondary analyses that use archived HIV/AIDS data sets and specimen collections to answer questions about maternal, pediatric, and adolescent HIV/AIDS. Both U.S. and foreign organizations are eligible to apply, but foreign components within a project are not allowed. The award ceiling is up to about $200,000.
ResearchersSchools & universitiesBroad eligibilitySingle-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI R61/R33 cooperative agreement funds investigator-initiated single-site clinical trials relevant to the NHLBI mission, using a milestone-driven, two-phase structure. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. Applicants are encouraged to include expertise in biostatistics and clinical trial design.
ResearchersSchools & universitiesBroad eligibilityData Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI U24 cooperative agreement funds a Data Coordinating Center to provide data management, biostatistics, and project coordination for investigator-initiated multi-site clinical trials. A companion Clinical Coordinating Center application must be submitted on the same due date for consideration. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilityClinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Due Nov 2, 2028National Institutes of Health · Amount varies
This NIH/NHLBI UG3/UH3 cooperative agreement funds a Clinical Coordinating Center to lead and operate investigator-initiated multi-site clinical trials relevant to the NHLBI mission. A companion Data Coordinating Center application must be submitted on the same due date. Both U.S. and foreign organizations may apply, but applications with funded foreign subawards/subcontracts will be rejected.
ResearchersSchools & universitiesBroad eligibilityEarly Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Due Nov 5, 2028National Institutes of Health · Up to $400K
This NIH R01 grant funds research into early immune system development from the prenatal period through early childhood, including effects of in-utero HIV or antiretroviral exposure. A broad range of applicants is eligible, including colleges and universities, tribal governments, faith- and community-based organizations, minority-serving institutions, and foreign organizations. The award ceiling is up to about $400,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreThe Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Due Nov 22, 2028National Institutes of Health · Up to $500K
This NIH/NCI U01 cooperative agreement funds research projects within the Metastasis Research Network that use systems-level approaches to study cancer metastasis as a whole-body problem. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. The award ceiling is up to about $500,000.
ResearchersSchools & universitiesLarge awardBroad eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · $0–$250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
Due Apr 4, 2029Dept of the Army -- Materiel Command · Amount varies
The Army Applications Lab Broad Agency Announcement funds basic and applied scientific research in defense-relevant areas described in the BAA. Eligibility is unusually broad: institutions of higher education, nonprofits, state and local governments, foreign organizations and public entities, and for-profit businesses (large and small) may all apply. No specific award amount is listed, and projects are selected through full and open competition, so applicants should review the BAA's stated research areas of interest.
ResearchersSmall businessNonprofitsSchools & universities+2 moreCHIPS Research and Development Office (CRDO) Broad Agency Announcement (BAA)
Due Sep 30, 2029National Institute of Standards and Technology · From $10M
This NIST CHIPS R&D Office Broad Agency Announcement funds research, prototyping, and commercial solutions that advance U.S. microelectronics technology, with a stated floor of about $10 million per award. Eligible applicants include for-profit and non-profit organizations, accredited universities, FFRDCs, and federal entities, but they must be domestic; individuals and unincorporated sole proprietors are not eligible. Some foreign partners may participate as subawardees, subject to restrictions (foreign adversaries excluded). Given the large award size, applicants should review the full BAA for compliance requirements.
Small businessNonprofitsSchools & universitiesResearchers+3 moreAir Dominance Broad Agency Announcement (BAA)
Due Oct 31, 2029Munitions Directorate · Up to $750M
This Air Force (Munitions Directorate) Broad Agency Announcement funds research and development supporting air dominance, with a program ceiling reported up to roughly $750 million. Eligibility is described as unrestricted and open to any type of entity, subject to any clarifications in the full announcement, making it broadly accessible to businesses, universities, and nonprofits. Because it is defense-focused R&D, applicants should expect security and compliance requirements and should review the full BAA for specifics.
ResearchersSmall businessNonprofitsSchools & universities+3 moreRFA-IP-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-IP-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The entry is a placeholder for Type 6 (continuation/competing renewal) applications and does not state award amounts or program specifics. Because it appears aimed at existing grantees, check with CDC about eligibility if you have not held a prior award.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-SH-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-SH-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no award amounts or detailed requirements listed. As it appears geared toward existing grantees, confirm eligibility with CDC before applying as a new organization.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-DD-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-DD-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder listing for renewal-type applications and provides no award amounts or detailed program requirements. As it appears geared toward existing grantees, confirm eligibility with CDC before applying as a new applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CD-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC health research opportunity (RFA-CD-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. It is a placeholder for Type 6 (continuation/competing renewal) applications, with no stated award amounts or specific requirements. Because it appears aimed at existing grantees, confirm eligibility with CDC if you are a first-time applicant.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-CE-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This is a CDC health research opportunity (RFA-CE-18-000) open to a broad range of applicants, including states, universities, counties, small businesses, and nonprofit organizations. It is described only as a placeholder for Type 6 (continuation/competing renewal) applications, so funding amounts and specific program details are not stated. Because it appears geared toward existing grantees submitting renewal-type applications, confirm with CDC whether new applicants are eligible before applying.
NonprofitsSmall businessResearchersGovernment / tribal+2 moreRFA-GH-18-000
Due Sep 30, 2030Centers for Disease Control and Prevention - ERA · $0
This CDC global health research opportunity (RFA-GH-18-000) is open to states, universities, counties, small businesses, and nonprofit organizations. The listing is a placeholder with minimal detail and no stated award amounts. Because such CDC RFA placeholders are typically used for renewal-type applications, verify with CDC whether new applicants are eligible and what the actual program scope is.
NonprofitsSmall businessResearchersGovernment / tribal+2 more